Biomimetic Spiky Nanoparticle Arrays as Tools to Explore Curvature Enhanced Nano-Bio Interactions
Project Number1R21EB035648-01
Contact PI/Project LeaderODOM, TERI WANG
Awardee OrganizationNORTHWESTERN UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY
Cells are dynamic, multiscale materials. Their ability to sense and respond to a wide variety of stimuli is
predicated on the hierarchical construction of the actin cytoskeleton, where individual actin monomers assemble
to form filaments, which themselves assemble to form more complicated structures. Therefore, to engineer nano-
bio interfaces that can stimulate a specific cellular response, we propose to test a biomimetic approach, where
our designer material will exhibit hierarchy and function across the same length scales as the cytoskeleton. This
project aims to engineer arrays of spiky gold nanoparticles with spike characteristics that are commensurate with
actin filaments and where the particle-particle spacing corresponds to the size of mature focal adhesions. Our
fabrication method is biocompatible, high-resolution, and high-throughput. We will investigate the physical effects
of topographical features across length scales as well as chemical effects. Since the smallest feature size of the
spiky nanoparticles (the tips) have radii of curvature tunable in the 5-10 nm range, we can test whether known
nanotopographical sensing pathways occur at length scales similar in size to single proteins as well as the effects
on cell phenotype resulting from reduced focal adhesion density. We will evaluate for synergistic effects between
nano- and microscale topographical sensing on contact guidance of the cytoskeleton by comparing responses
from different spike and nanoparticle array geometries.
As a model problem, we aim to manipulate the process of macropinocytosis. While nanoscale curvature is
known to promote clathrin-mediated endocytosis, the effects of curvature on macropinocytosis remain unclear.
By varying the spike features of the nanoparticles and the DNA-aptamer functionalization of their surfaces, we
will test for synergy between two factors: (1) enhanced rates of macropinocytosis via receptor binding to the DNA
ligands; and (2) effects of priming the cell membrane for macropinocytosis through nanotopographical curvature.
We expect that our biomimetic approach enabled by spiky nanoparticle arrays will have a significant impact on
a range of questions in biotechnology, from fundamental mechanisms for early-stage endocytosis to applications
such as biofouling-resistant sensors and the use of topographical cues as mechanobiological stimuli.
Public Health Relevance Statement
PROJECT NARRATIVE
The intersection of nanomaterials and biology has produced promising tools for selective drug delivery, bio-
imaging, and biosensing. This project will design structured nano- and microscale materials with topographical
features similar to that of the extracellular matrix. This platform to investigate nano-bio interfaces will allow control
over cellular motion, adhesion, and shape that will then enable more targeted diagnostics and therapeutics.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
160079455
UEI
EXZVPWZBLUE8
Project Start Date
15-March-2024
Project End Date
28-February-2026
Budget Start Date
15-March-2024
Budget End Date
28-February-2025
Project Funding Information for 2024
Total Funding
$211,552
Direct Costs
$135,000
Indirect Costs
$76,552
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$211,552
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21EB035648-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21EB035648-01
Patents
No Patents information available for 1R21EB035648-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21EB035648-01
Clinical Studies
No Clinical Studies information available for 1R21EB035648-01
News and More
Related News Releases
No news release information available for 1R21EB035648-01
History
No Historical information available for 1R21EB035648-01
Similar Projects
No Similar Projects information available for 1R21EB035648-01